# FDA Inspection 1219130 - Tayca Corporation - August 25, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/tayca-corporation/6cd9ce85-bb7f-4a1a-9855-15ddab3b11ee
Source feed: FDA_Inspections

> FDA Inspection 1219130 for Tayca Corporation on August 25, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219130
- Company Name: Tayca Corporation
- Inspection Date: 2023-08-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1038594 - 2017-12-15](https://www.globalkeysolutions.net/records/fda_inspections/tayca-corporation/4946f71a-6848-47ff-8d8d-64ca1532a937)
- [FDA Inspection 989845 - 2016-09-09](https://www.globalkeysolutions.net/records/fda_inspections/tayca-corporation/1cd4f937-6e2d-4d37-b93b-2e1e9123cea8)
- [FDA Inspection 855688 - 2013-11-08](https://www.globalkeysolutions.net/records/fda_inspections/tayca-corporation/b931b3f7-3767-47c6-8163-5adda8f36049)
- [FDA Inspection 615187 - 2009-08-27](https://www.globalkeysolutions.net/records/fda_inspections/tayca-corporation/0d87c2b8-25bc-4a78-952f-02327e865218)

Company: https://www.globalkeysolutions.net/companies/tayca-corporation/46216ddd-c2d8-492b-bbc2-7011e93a98bf

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c